Brief: Microbix Biosystems Announces U.S. Availability Of Four Innovative In-Vitro Diagnostic (IVD) Control Products
19/09/2019 12:15
Sept 19 (Reuters) - Microbix Biosystems Inc MBX.TO :
* MICROBIX BIOSYSTEMS - ANNOUNCES U.S. AVAILABILITY OF FOUR
INNOVATIVE IN-VITRO DIAGNOSTIC (IVD) CONTROL PRODUCTS
Source text for Eikon: ID:nGNX8bfmMP
Further company coverage: MBX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbix Biosystems
See all newsCanada's Microbix Q3 revenue rises on higher antigen, QAPs sales
Brief: Microbix Biosystems Q3 Revenue CAD 4.1 Million
Canada's Microbix Biosystems Q2 revenue falls 37% on weaker China sales
Canada's Microbix Q1 revenue down 30% on China sales decline
Brief: Microbix Biosystems Q1 Revenue CAD 4.2 Million